# Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

> **NCT04818892** · — · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 222 (actual)

## Conditions studied

- IBD
- Covid19 Vaccine

## Interventions

- **DIAGNOSTIC_TEST:** Serological Assay for SARS-CoV-2

## Key facts

- **NCT ID:** NCT04818892
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2022-11-11
- **Final completion:** 2022-11-11
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818892, "Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04818892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*